FOS and neoplasm: Hence strategies to increase cFos transcription could be valuable in making malignant cells vulnerable to apoptosis, and HXR9 may synergise with TRAIL and other drugs that induce apoptosis to facilitate enhanced cell killing across a broad range of tumour types.